Skip to content

Intravascular Injection Incidences During Lumbar Medial Branch Block

Comparison of Intravascular Injection Incidences Durig Lumbar Medial Branch Block Using Anteroposterior or Oblique Angle

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05362084
Enrollment
32
Registered
2022-05-05
Start date
2021-09-03
Completion date
2022-04-30
Last updated
2022-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intravascular Injection

Keywords

intravascular injection

Brief summary

The purpose of this study is to compare using oblique fluoroscopic angle has any advantage in reducing the incidence of vascular punture and technical easiness during lumbar medial branch block

Detailed description

In previous report, the use of oblique fluoroscopic angle during S1 transforaminal injection demonstrated technical easiness and reduced intravascular injection incidences. For the procedure lumbar medial branch block, both anteroposterior and oblique fluoroscopic angle are possible. Usually, which approach method to use is determined according to the physician's preferences. The final target for lumbar medial branch block is the junction betweeen superior articular process and transverse process. This target can be easily confirmed under the scotty dog appearance. If we use oblique fluoroscopic angle, this approach (30 degree) can make scotty dog appearance more visible so that physician can identify bony landmark more easily for lumbar medial branch block. For beginners, oblique fluoroscopic approach seems to provide more advantages in identifying bony landmark. However, it is uncertain whether this approach can provide technicaL easiness and reduce the intravascualr injection incidences.

Interventions

lumbar medial branch block

Sponsors

Keimyung University Dongsan Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* facet joint arthropathy

Exclusion criteria

* allergy to local anesthetics or contrast medium * pregnancy * spine deformity * neurologic abnormality

Design outcomes

Primary

MeasureTime frameDescription
incidence of intravasuclar injection1 minute after finishing lumbar medial branch blockincidence of intravasuclar injection

Secondary

MeasureTime frameDescription
time required to complete lumbar medial branch block1 second after finishing lumbar medial branch blocktime required to complete lumbar medial branch block
radiation amount to complete lumbar medial branch block1 second after finishing lumbar medial branch blockradiation amount to complete lumbar medial branch block

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026